Загрузка...
GLP-1 receptor agonists: a review of head-to-head clinical studies
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are attractive options for the treatment of type 2 diabetes (T2D) because they effectively lower A1C and weight while having a low risk of hypoglycemia. The GLP-1 RA class has grown in the last decade with several agents available for use in the U...
Сохранить в:
| Опубликовано в: : | Ther Adv Endocrinol Metab |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4321870/ https://ncbi.nlm.nih.gov/pubmed/25678953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042018814559725 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|